Bing Xia
- Molecular Biology top 0.5%
- DNA Repair Mechanisms 38
- CRISPR and Genetic Engineering 18
- RNA modifications and cancer 12
- Cancer Research top 1%
- Genetics top 0.5%
- BRCA gene mutations in cancer 22
- Inflammatory Bowel Disease 18
- Oncology top 1%
- Lung Cancer Research Studies 24
- Immunology top 5%
-
- Lung Cancer Treatments and Mutations 33
- Lung Cancer Diagnosis and Treatment 13
Bing Xia
255 papers receiving 9.9k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Molecular Biology 7.1k
- Cancer Research 1.4k
- Genetics 2.5k
- Oncology 2.3k
- Immunology 766
Countries citing papers authored by Bing Xia
This map shows the geographic impact of Bing Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Xia more than expected).
Fields of papers citing papers by Bing Xia
This network shows the impact of papers produced by Bing Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Xia. The network helps show where Bing Xia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bing Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 55 | |
| 9 | 2021 | 18 | |
| 10 | 2020 | 75 | |
| 11 | 2019 | 20 | |
| 12 | 2017 | 148 | |
| 13 | 2015 | 30 | |
| 14 | 2014 | 30 | |
| 15 | 2013 | 111 | |
| 16 | 2012 | 48 | |
| 17 | 2010 | 1 | |
| 18 | Investigation on Spore Germination of Sphenomeris chinensis (Lindsaeaceae) | 2008 | 3 |
| 19 | RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sitesbreakdown → | 2007 | 553 |
| 20 | Optimum on induction and proliferation of adventitious buds from Zantedeschia hybrida 'Parfait' in vitro | 2006 | 1 |
About Bing Xia
Bing Xia is a scholar working on Oncology, Genetics and Molecular Biology, having authored 268 papers that have together received 10.1k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (38 papers), Lung Cancer Treatments and Mutations (33 papers), Lung Cancer Research Studies (24 papers), BRCA gene mutations in cancer (22 papers), CRISPR and Genetic Engineering (18 papers), Inflammatory Bowel Disease (18 papers), Lung Cancer Diagnosis and Treatment (13 papers) and RNA modifications and cancer (12 papers). The work is most often cited by research in Molecular Biology (7.1k citations), Cancer Research (1.4k citations) and Genetics (2.5k citations). Bing Xia has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Masayori Inouye, David M. Livingston, Dima Kozakov, Sándor Vajda, Eileen White, Jessie Yanxiang Guo, Hong Cai, Haiping Ke, Kathryn A. Porter and Jianglin Ma. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Cancer Research, Annals of Oncology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.